Citations

Clear

4847 citation(s) found for "Tu, Eric".

Genetic variants associated with risk of Alzheimer's disease contribute to cognitive change in midlife: The Atherosclerosis Risk in Communities Study
Bressler, Jan , Penman, Alan D. , Gottesman, Rebecca F., Windham, B. Gwen , Wruck, Lisa , Boerwinkle, Eric , Mosley, Thomas H. , Knopman, David S. , Wruck, Lisa M

Mayo Clinic

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics | October 26, 2016 | Volume: 174 | Issue: 3 | Pages: 269-282

10.1002/ajmg.b.32509 | PMID 27781389 Get It

Alzheimer's disease (AD) is the most common form of dementia and is characterized by impairment in memory, behavioral changes, and gradual loss of autonomy. Since there is a long latent period prior to diagnosis, the aim of this study was to determine whether twenty single nucleotide polymorphisms identified in genome‐wide association analyses of AD are associated with cognitive change in 8,320 white and 2,039 African‐American middle‐aged adults enrolled in the prospective Atherosclerosis Risk in Communities (ARIC) study. Cognition was evaluated using the Delayed Word Recall Test (DWRT; verbal memory), Digit Symbol Substitution Test (DSST; processing speed), and Word Fluency Test (WFT; executive function). General linear models were used to assess mean differences in 6‐year change in test scores among individuals categorized by genotype after adjusting for age, gender, and years of education. Addition of the minor allele for rs670139 (MS4A4E), rs9331896 (CLU), and rs12155159 (NME8) was nominally associated with change on the DWRT, DSST, and WFT, respectively, in whites. The ZCWPW1(rs1476679) andCDS33(rs3865444) variants were nominally associated with change on the DWRT and WFT in African‐Americans. For rs670139 and rs9331896 the association was only significant in individuals bearing at least oneAPOEϵ4 allele in stratified analyses. An unweighted genetic risk score aggregating the risk alleles for 15 polymorphisms was not associated with change in cognitive function. Although the AD‐associated genetic variants appear to have small effects on early cognitive change, replication will be required to establish whether there is a discernible influence on cognitive status in midlife. © 2016 Wiley Periodicals, Inc.
Incidence and time trends of drug‐induced parkinsonism: A 30‐year population‐based study
Savica, Rodolfo , Grossardt, Brandon R. , Bower, James H., Ahlskog, J. Eric , Rocca, Walter A. , Mielke, Michelle M. , Grossardt, Brandon R

Mayo Clinic

Movement Disorders | October 25, 2016 | Volume: 32 | Issue: 2 | Pages: 227-234

10.1002/mds.26839 | PMID 27779780 Get It

ABSTRACT Background Epidemiological studies of drug‐induced parkinsonism remain limited. Objectives To investigate the incidence and time trends of drug‐induced parkinsonism over 30 years in a geographically defined American population. Methods We used the medical records‐linkage system of the Rochester Epidemiology Project to identify all persons in Olmsted County, Minnesota, who received a screening diagnostic code for parkinsonism from 1976 through 2005. A movement disorders specialist reviewed the complete medical records of each person to confirm the presence of drug‐induced parkinsonism associated with dopamine‐blocking or dopamine‐depleting medications. Results Among 906 incident cases of parkinsonism from 1976 to 2005, 108 persons had drug‐induced parkinsonism (11.9%). The average annual incidence rate of drug‐induced parkinsonism was 3.3 per 100,000 person‐years, was higher in women, and increased with older age. Drug‐induced parkinsonism was the fifth‐most common type of parkinsonism overall; however, it was the most common type among persons younger than age 40 years. Typical antipsychotic drugs were the most common class of drugs associated with parkinsonism, whereas atypical antipsychotic drugs were rarely involved. The incidence rate of drug‐induced parkinsonism decreased 32.0% per decade (relative risk = 0.68; 95% confidence interval: 0.49–0.94) and 68.6% over the 30 years of the study. The decrease was similar in men (65.2%) and women (69.4%); however, the trend was significant only in women. Conclusions The incidence of drug‐induced parkinsonism increased with older age and was higher in women at all ages. Typical antipsychotic drugs were the most common cause. The incidence of drug‐induced parkinsonism decreased over the 30 years of the study because of changes in drug use. © 2016 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
Comparison of Open Drainage Versus Closed Catheter Irrigation for Treatment of Suppurative Flexor Tenosynovitis
Born, Trevor, Wagner, Eric R. , Born, Trevor R, Kakar, Sanjeev , Wagner, Eric R

Mayo Clinic

HAND | October 24, 2016 | Volume: 12 | Issue: 6 | Pages: 579-584

10.1177/1558944716675131 | PMID 29091483 Get It

Background: The purpose of this study was to review the outcomes associated with different surgical treatments in the management of suppurative flexor tenosynovitis (SFT). Methods: Patients treated by open drainage (OD) through a single incision and closed catheter irrigation (CCI) of the tendon sheath were evaluated from 2003 to 2009 at a single institution. Variables examined included culture results, time to surgery, duration of hospitalization and antibiotic therapy, pain, reoperation, and functional outcomes were recorded. Statistical analyses used included parametric and nonparametric t tests. Results: Twenty-four patients were treated for SFT with a mean follow-up of 3 ± 2 years. There were 13 (100%) males in the OD group compared to 8 (72%) males within the CCI group. Ninety-two percent of patients who underwent OD and 100% who underwent CCI reported none or mild pain. There were no differences between the 2 groups with regard to functional outcome scores. Factors leading to worse functional outcomes included prolonged time to receiving antibiotics and Staphylococcus aureus infection. Smokers required prolonged antibiotic treatment compared to nonsmokers. Accounting for planned returns to the operating room, there was no difference in reoperation rates between the OD or CCI groups. Conclusions: Surgical treatment of SFT with either OD or CCI resulted in similar outcomes for pain, function, and need for reoperation. Factors that lead to poor outcomes include S aureus culture, prolonged time to antibiotics, and smoking.
Febrile infection‐related epilepsy syndrome treated with anakinra
Kenney‐Jung, Daniel , Vezzani, Annamaria , Kahoud, Robert J., LaFrance‐Corey, Reghann G., Ho, Mai‐Lan , Muskardin, Theresa Wampler , Howe, Charles L. , Payne, Eric T. , Kenney-Jung, Daniel L, Wirrell, Elaine C., Wirrell, Elaine , Ho, Mai-Lan , Howe, Charles L , Vezzani, Annamaria

Mayo Clinic

Annals of Neurology | October 22, 2016 | Volume: 80 | Issue: 6 | Pages: 939-945

10.1002/ana.24806 | PMID 27770579 Get It

Febrile infection‐related epilepsy syndrome (FIRES) is a devastating epileptic encephalopathy with limited treatment options and an unclear etiology. Anakinra is a recombinant version of the human interleukin‐1 receptor antagonist used to treat autoinflammatory disorders. This is the first report of anakinra for treatment of a child with super‐refractory status epilepticus secondary to FIRES. Anakinra was well tolerated and effective. Cerebral spinal fluid analysis revealed elevated levels of proinflammatory cytokines before treatment that normalized on anakinra, suggesting a potential pathogenic role for neuroinflammation in FIRES. Further studies are required to assess anakinra efficacy and dosing, and to further delineate disease etiology. Ann Neurol 2016;80:939–945
Epidemiology of Polymyalgia Rheumatica 2000–2014 and Examination of Incidence and Survival Trends Over 45 Years: A Population‐Based Study
Raheel, Shafay , Shbeeb, Izzat, Crowson, Cynthia S. , Matteson, Eric L.

Mayo Clinic

Arthritis Care & Research | October 21, 2016 | Volume: 69 | Issue: 8 | Pages: 1282-1285

10.1002/acr.23132 | PMID 27768840 Get It

ObjectiveTo determine time trends in the incidence and survival of polymyalgia rheumatica (PMR) over a 15‐year period in Olmsted County, Minnesota, and to examine trends in incidence of PMR in the population by comparing this time period to a previous incidence cohort from the same population base.MethodsAll cases of incident PMR among Olmsted County, Minnesota residents in 2000–2014 were identified to extend the previous 1970–1999 cohort. Detailed review of all individual medical records was performed. Incidence rates were age‐ and sex‐adjusted to the US white 2010 population. Survival rates were compared with the expected rates in the population of Minnesota.ResultsThere were 377 incident cases of PMR during the 15‐year study period. Of these, 64% were female and the mean age at incidence was 74.1 years. The overall age‐ and sex‐adjusted annual incidence of PMR was 63.9 (95% confidence interval [95% CI] 57.4–70.4) per 100,000 population ages ≥50 years. Incidence rates increased with age in both sexes, but incidence fell after age 80 years. There was a slight increase in incidence of PMR in the recent time period compared to 1970–1999 (P = 0.063). Mortality among individuals with PMR was not significantly worse than that expected in the general population (standardized mortality ratio 0.70 [95% CI 0.57–0.85]).ConclusionThe incidence of PMR has increased slightly in the past 15 years compared to previous decades. Survivorship in patients with PMR is not worse than in the general population.
Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans
Chung, Jaeyoon , Jun, Gyungah , Kriegel, Joshua, Bourlas, Alexandra P., Sherva, Richard , Barnes, Lisa L. , Bennett, David A. , Buxbaum, Joseph D. , Byrd, Goldie S. , Crane, Paul K. , Ertekin‐Taner, Nilüfer , Evans, Denis A., Fallin, M. Daniele , Goate, Alison , Graff‐Radford, Neill R. , Hall, Kathleen, Kukull, Walter A. , Larson, Eric B., Haines, Jonathan L. , Mayeux, Richard , Pericak‐Vance, Margaret A. , Schellenberg, Gerard D. , Lunetta, Kathryn L. , Farrer, Lindsay A. , Bennett, David A. , Mez, Jesse , Sherva, Richard , Logue, Mark W. , Foroud, Tatiana , Kamboh, M. Ilyas , Manly, Jennifer J. , Goate, Alison M , Barnes, Lisa L

Mayo Clinic

Alzheimer's & Dementia | October 20, 2016 | Volume: 13 | Issue: 2 | Pages: 119-129

10.1016/j.jalz.2016.09.002 | PMID 27770636 Get It

AbstractIntroductionAfrican Americans' (AAs) late‐onset Alzheimer's disease (LOAD) genetic risk profile is incompletely understood. Including clinical covariates in genetic analyses using informed conditioning might improve study power.MethodsWe conducted a genome‐wide association study (GWAS) in AAs employing informed conditioning in 1825 LOAD cases and 3784 cognitively normal controls. We derived a posterior liability conditioned on age, sex, diabetes status, current smoking status, educational attainment, and affection status, with parameters informed by external prevalence information. We assessed association between the posterior liability and a genome‐wide set of single‐nucleotide polymorphisms (SNPs), controlling for APOE and ABCA7, identified previously in a LOAD GWAS of AAs.ResultsTwo SNPs at novel loci, rs112404845 (P = 3.8 × 10−8), upstream of COBL, and rs16961023 (P = 4.6 × 10−8), downstream of SLC10A2, obtained genome‐wide significant evidence of association with the posterior liability.DiscussionAn informed conditioning approach can detect LOAD genetic associations in AAs not identified by traditional GWAS.
Left ventricular non-compaction cardiomyopathy: Incidental diagnosis after ST-elevation myocardial infarction
Liang, Jackson J. , Fenstad, Eric R. , Janish, Christopher D., Sinak, Lawrence J., Liang, Jackson

Mayo Clinic

Acute Cardiac Care | October 18, 2016 | Volume: 18 | Issue: 1 | Pages: 25-27

10.1080/17482941.2016.1234055 | PMID 27754701 Get It

P1‐325: Predicting Progression to Mild Cognitive Impairment in Cognitively Unimpaired Individuals Using Neuroimaging Biomarkers
Stonnington, Cynthia M. , Lee, Wendy , Bauer, Robert, Sharieff, Sameen, Chen, Yinghua , Caselli, Richard J. , Reiman, Eric M. , Locke, Dona E.C. , Chen, Kewei

Mayo Clinic

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_11 | Pages: No page available

10.1016/j.jalz.2016.06.1076 Get It